Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |